Core Viewpoint - The company has signed an investment cooperation agreement with the Xi'an Economic and Technological Development Zone Management Committee to establish a medical equipment and testing reagent production base and a medical industry incubation innovation center, covering approximately 90 acres of land [3][5]. Group 1: Agreement Overview - The agreement was signed on April 8, 2025, and is structured in two phases: the first phase involves a production base for medical equipment and testing reagents on approximately 50 acres, while the second phase will focus on a medical industry incubation center on about 40 acres [3][5]. - The first phase aims to produce 72 million testing reagents and 3,000 sets of testing equipment annually upon completion [5]. Group 2: Counterparty Information - The counterparty, Xi'an Economic and Technological Development Zone Management Committee, is a national-level economic and technological development zone established in 1993, focusing on advanced manufacturing and export-oriented economic development [4]. Group 3: Agreement Details - The company will establish an independent legal entity in the Xi'an Economic and Technological Development Zone to manage the project, ensuring compliance with local planning and legal requirements [6]. - The management committee will provide land and support for project approvals, environmental protection, and safety [6]. Group 4: Impact on the Company - The agreement is a framework and does not affect the company's operational independence; the financial impact will depend on the execution of specific project agreements in the future [7].
上海科华生物工程股份有限公司 关于公司签署投资合作协议的公告